CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
No interventionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02519049
NCT02519049N/ACompleted
CompareCT.gov

Diagnostic and Prognostic Role of 11C-Methionine PET/CT Imaging in Patients Affected by Malignant Pleural Mesothelioma (MPM) and Candidate to Pleurodesis

Istituto Clinico Humanitas·observational·Posted Aug 10, 2015·Updated Oct 1, 2020

In Brief

An observational study evaluating No intervention for Mesothelioma, Malignant. Completed, enrolled 30 participants across 1 site.

Detailed Summary

Prospective exploratory study specifically investigating the role of 11C-Methionine PET/CT imaging in patients affected by Malignant Pleural Mesothelioma (MPM) and candidate to pleurodesis.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsMesothelioma, Malignant
CountriesItaly
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedAug 10, 2015
Enrollment StartSep 1, 2014
Primary CompletionSep 1, 2018
Study CompletionDec 1, 2018
TodayJul 2, 2026
Enrollment to primary: 4 yearsPosted 10.9 years ago

Interventions

No interventionother

This is an observational study